Hormone pellets and Biote

Biote HER-T: What It Is and What the Evidence Says About Testosterone for Women

The short answer

Biote HER-T is a nutraceutical that Biote says is designed to support healthy testosterone balance in women. It is not a hormone pellet or a prescription testosterone product, and its claims carry the standard note that they have not been evaluated by the FDA. Prescription testosterone has a narrower evidence base than many people expect: an international consensus statement found its only evidence-based use in women is distressing low sexual desire (HSDD) after menopause.

What is Biote HER-T?

If you have searched “Her T” or “Biote Her-T,” you may have seen it described in different ways, including as a testosterone pellet. Biote’s own pages describe something else. On its nutraceuticals page, Biote lists HER-T as “Healthy Testosterone Balance Support for Women,” alongside its other supplement products, and says it supports healthy testosterone balance, balanced cortisol levels, and health and longevity.

The HER-T product page calls it “one of Biote’s newest nutraceuticals,” designed to support healthy testosterone balance in women in a “naturally-derived, science-based formulation.” Biote says it may support “multi-mechanistic hormone balance,” naming selective estrogen receptor modulation, prolactin, aromatase, five-alpha reductase and luteinizing hormone. The page says HER-T may benefit adult women over 18 who are not pregnant or breastfeeding, and that it can be used with or without hormone therapy.

Three things are worth knowing up front:

  • It is a nutraceutical, not a prescription hormone. Biote’s claims about HER-T carry an asterisk pointing to the statement that they have not been evaluated by the Food and Drug Administration.
  • The ingredient list isn’t on the product page text. Biote’s page describes what the formula is meant to do but does not list ingredients or amounts, so check the Supplement Facts panel on the bottle itself.
  • We found no published trials of the formula. We could not find clinical studies of HER-T in PubMed. Biote’s page points to research on testosterone levels in women in general, which is a different question from whether this product changes them.

How is HER-T different from Biote testosterone pellets?

Biote is best known for hormone pellet therapy. Its pellet FAQ describes testosterone pellets as powdered testosterone fused into a pellet with stearic acid, inserted under the skin of the upper buttock by a Biote-certified provider after lab work, and repeated two to four times a year. That is a compounded prescription medicine. HER-T is something you swallow and buy as a nutraceutical. Here is how the options people often confuse compare.

Biote HER-TBiote testosterone pelletsTransdermal testosterone at female doses
What it isNutraceutical Biote says supports testosterone balanceCompounded testosterone pellet placed under the skinCream or gel applied daily
Prescription neededNoYes, from a certified providerYes
FDA statusNot evaluated for its claimsCompounded, not FDA-approvedNo US product approved for women; used off-label
Changing the doseStop or change any dayFixed until the pellet dissolvesCan be adjusted at the next prescription
Evidence in womenNo published trials foundMostly observational studiesRandomized trials for HSDD after menopause

Does testosterone actually help women?

Testosterone is a normal hormone in women, and levels fall gradually with age. But the evidence for treating women with it is narrower than marketing often suggests.

The Global Consensus Position Statement on testosterone for women, published in 2019 and endorsed by The Endocrine Society, The Menopause Society and other international groups, concluded that the only evidence-based use of testosterone in women is for postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD), meaning low desire that causes real distress, after a full assessment. That is a specific endorsement, not a general one. The same statement found:

  • No effect of testosterone on general wellbeing in postmenopausal women.
  • Not enough evidence to use it for memory, thinking or preventing cognitive decline.
  • Its recommendations do not apply to pellets, injections, compounded products, or anything that raises testosterone above the normal female range.
  • A blood testosterone level should not be used to diagnose HSDD.

The benefit, where it exists, is modest. In a meta-analysis of 36 randomized trials with almost 8,500 women, testosterone added just under one extra satisfying sexual event per month (0.85) compared with placebo or a comparator, along with improvements in desire, arousal and orgasm. It found no effect on body composition, muscles, bones or cognition, though few women contributed data on those. The Endocrine Society’s 2014 guideline recommends against general use of testosterone for cognitive, cardiovascular, metabolic or bone health, or for wellbeing. For more on the libido question, see our guide to testosterone and libido in women.

By the numbers

Testosterone for low desire: the trial evidence

36randomized trials pooled, with almost 8,500 womenSource: Islam 2019
0.85extra satisfying sexual events per month vs. placebo or comparatorSource: Islam 2019

What do pellets mean for testosterone dosing?

If you are comparing HER-T with Biote’s testosterone pellets, the delivery method matters as much as the hormone. Once a pellet is in, it releases hormone until it dissolves. You can’t lower the dose partway through, and the pellet isn’t designed to be removed.

  • Levels can run high. A 2025 review of 38 studies found testosterone pellets in women produce early peaks above the normal female range (over 100 to 250 ng/dL) with wide variation from person to person. In a records study of 539 postmenopausal women, average peak testosterone was 194 ng/dL with pellets versus about 16 ng/dL with FDA-approved hormone therapy, and side effects were more common in the pellet group.
  • Guidance favors other forms. ACOG recommends preparations other than pellets for testosterone, citing the lack of safety data and the inability to remove the pellet. It advises keeping levels in the premenopausal range of 20 to 80 ng/dL.
  • The evidence is mostly observational. The 2025 review found one small randomized trial of pellets. It concluded that pellet benefits remain “hypothesis-generating” and that safety cannot yet be confirmed.

By the numbers

Pellet testosterone levels vs. the target range

194 ng/dLaverage peak testosterone with pelletsSource: Jiang 2021
~16 ng/dLaverage peak with FDA-approved hormone therapySource: Jiang 2021
20–80 ng/dLpremenopausal range ACOG advises keeping levels withinSource: ACOG 2023

Our guide to how hormone pellet therapy works covers the procedure itself.

What are the side effects of testosterone for women?

In the trial meta-analysis, women on testosterone were more likely to report acne and unwanted hair growth than women on placebo, and an overall increase in weight was recorded. ACOG lists hirsutism, acne and other masculinizing effects, which may be permanent, among the most common adverse events, and notes that the long-term effects on heart disease and breast cancer risk are unknown. ACOG also notes that studies of testosterone pellets have reported perceived voice changes, mood swings and anxiety. These effects are harder to manage when the dose can’t be turned down. Our page on hormone pellet side effects goes through what is common and what needs a call to your clinician.

What are the alternatives to HER-T or testosterone pellets?

The right choice depends on what you are trying to fix. Many women looking at HER-T are dealing with low desire, low energy or menopause symptoms, and those have different answers.

  • Distressing low desire after menopause: ask about transdermal testosterone dosed to stay in the female range, with a blood level checked before and a few weeks after starting, as the consensus statement recommends.
  • Low desire before menopause: two medicines are FDA-approved for HSDD. Addyi (flibanserin) is a nightly pill approved for acquired, generalized HSDD in women under 65, and Vyleesi (bremelanotide) is an as-needed injection for premenopausal women that modestly improved desire in two phase 3 trials.
  • Hot flashes, night sweats and poor sleep: estrogen is the most effective treatment, with progesterone added to protect the uterus if you have one. FDA-approved estradiol and progesterone products are available in many forms; our guide to hormone replacement therapy explains the choices. Better sleep and fewer night sweats can also help energy and desire.
  • Painful sex or dryness: low-dose vaginal estrogen, moisturizers and lubricants often help desire indirectly.

Amie HRT+ is one prescription option for menopause symptoms: a single compounded cream with estradiol and progesterone, at a strength a licensed clinician chooses after an online review. Like Biote pellets, it is compounded and not FDA-approved. Unlike a pellet, it is used at home, and the clinician can change the strength at the next prescription. It does not contain testosterone and is not a libido treatment, and a clinician decides whether it is appropriate for you.

Questions to ask before you try HER-T or pellets

  • What exactly am I hoping this will change, and how will we know if it worked?
  • For HER-T: what is on the Supplement Facts panel, and could any ingredient interact with my medicines?
  • For testosterone: have other causes of low desire, such as pain, mood, medicines, sleep or relationship stress, been looked at first?
  • What testosterone level are you aiming for, and when will you recheck it?
  • What happens if I get acne, hair growth or voice changes?
  • Would an FDA-approved product, or a form I can stop quickly, work for me instead?

For a broader look at safety, read is Biote safe?, or browse the pellets and Biote hub.

Common questions

Is Biote HER-T a testosterone pellet?

No. Biote lists HER-T among its nutraceuticals and describes it as a naturally derived formulation designed to support healthy testosterone balance in women. Biote’s testosterone pellets are a separate, compounded prescription product inserted under the skin by a Biote-certified provider.

Is Biote HER-T FDA-approved?

No. HER-T is sold as a nutraceutical, and Biote’s product claims carry the note that they have not been evaluated by the FDA. Supplements are not reviewed for effectiveness before they are sold.

What is in Biote HER-T?

Biote’s HER-T product page describes the formula’s intended actions but does not list the ingredients and amounts in its text. Read the Supplement Facts panel on the bottle, and show it to your clinician or pharmacist, especially if you take other medicines or hormones.

Are there studies on Biote HER-T?

We could not find any published clinical trials of the HER-T formula itself in PubMed. The research Biote’s page refers to is about testosterone levels in women in general, not about this product.

Does testosterone help women’s libido?

For postmenopausal women with distressing low desire (HSDD), carefully dosed non-oral testosterone has a modest benefit in trials. Guidelines do not support testosterone for general wellbeing, mood or energy, and they advise against pellets or any preparation that pushes levels above the normal female range.

Sources

  1. Biote. HER-T (nutraceuticals product page)
  2. Biote. Nutraceuticals
  3. Biote. Hormone pellet therapy FAQ
  4. Davis SR et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab 2019
  5. Islam RM et al. Safety and efficacy of testosterone for women: systematic review and meta-analysis. Lancet Diabetes Endocrinol 2019
  6. Wierman ME et al. Androgen therapy in women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014
  7. ACOG Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy (2023)
  8. Pinto da Costa Viana D et al. Testosterone pellets in women: revisiting safety and clinical outcomes. Cureus 2025
  9. Jiang X et al. Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in postmenopausal women. Menopause 2021
  10. Kingsberg SA et al. Bremelanotide for the treatment of HSDD: two randomized phase 3 trials. Obstet Gynecol 2019
  11. DailyMed. Addyi (flibanserin) prescribing information

Amie prescribes in all 50 states. Find online hrt in your state.